Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Thrombosis Research

• Publication date

  1998-05-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0049-3848(98)00050-4PMID 9692617
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina.

  1997cited by this paper
• A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions.

  1997cited by this paper
• Platelets and shear stress.

  1996cited by this paper
• Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasis.

  1996cited by this paper
• Potential mechanisms promoting restenosis in diabetic patients.

  1996cited by this paper
• Cardiovascular Disease and Its Risk Factors in IDDM in Europe

  1996cited by this paper
• Exposure of Adhesion Molecules on Activated Platelets in Patients with Newly Diagnosed IDDM Is Not Normalized by Near-Normoglycemia

  1995cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

  1994cited by this paper
• Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.

  1994cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

  1994cited by this paper
• Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients.

  1994cited by this paper
• A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy

  1994cited by this paper
• “Spontaneous” Platelet Aggregation in Whole Blood in Diabetic and Non Diabetic Survivors of Acute Myocardial Infarction

  1993cited by this paper
• Can restenosis after coronary angioplasty be predicted from clinical variables?

  1993cited by this paper
• Restenosis after Arterial Injury Caused by Coronary Stenting in Patients with Diabetes Mellitus

  1993cited by this paper
• Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

  1993cited by this paper
• The influence of lipoproteins on blood platelets.

  1993cited by this paper
• Platelets in Diabetes: The Role in the Hemostatic Regulation in Atherosclerosis

  1993cited by this paper
• Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators.

  1992cited by this paper
• Platelet Abnormalities in Diabetes Mellitus

  1992cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

  1992cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

  1992cited by this paper
• The effect of antihypertensive drugs on in vivo platelet activity in essential hypertension

  1992cited by this paper
• Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men.

  1992cited by this paper
• Comparison of the Effects of Carvedilol, Propranolol, and Verapamil on in vitro Platelet Function in Healthy Volunteers

  1991cited by this paper
• The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty.

  1991cited by this paper
• Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study.

  1991cited by this paper
• The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.

  1991cited by this paper
• Platelet hyperreactivity and prognosis in survivors of myocardial infarction.

  1990cited by this paper
• Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients.

  1989cited by this paper
• Evaluation of the clinical utility of platelet aggregation studies

  1989cited by this paper
• Effect of methotrexate on relapse after bone-marrow transplantation for acute lymphoblastic leukaemia

  1989cited by this paper
• Thromboxane biosynthesis and platelet function in type I diabetes mellitus.

  1988cited by this paper
• Platelet Lipoprotein Interactions

  1988cited by this paper
• Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

  1988cited by this paper
• Lipoprotein metabolism in diabetes mellitus.

  1987cited by this paper
• Do Platelets Have Anything To Do With Diabetic Microvascular Disease?

  1983cited by this paper
• Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro.

  1982cited by this paper
• PLATELET FUNCTION IN DIABETES MELLITUS

  1980cited by this paper
• Effects of Dietary and Pharmacologic Alteration of Serum Lipids on Platelet Survival Time

  1978cited by this paper
• Letter: Lupus erythematosus and brain scanning.

  1975cited by this paper
• Increased platelet aggregation in early diabetus mellitus.

  1975cited by this paper
• HL-A AND INFECTIVE SACROILEITIS

  1974cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• Increased platelet aggregation in diabetes mellitus.

  1972cited by this paper

• Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients

  2023cites this paper
• Gestational Diabetes Melitus and Cord Blood Platelet Function Studied via the PFA-100 System

  2022cites this paper
• The association between glycaemic control during hospitalization and risk of adverse events: A retrospective cohort study

  2021cites this paper
• Dysregulated pathways and differentially expressed proteins associated with adverse transfusion reactions in different types of platelet components.

  2020cites this paper
• Apoptotic cell death in heart failure associated with diabetes

  2019cites this paper
• In-Hospital Implementation of Evidence-Based Medications is Associated with Improved Survival in Diabetic Patients with Acute Coronary Syndrome - Data from TSOC ACS-DM Registry.

  2018cites this paper
• Long-term Prognosis and Clinical Characteristics of Patients with Newly Diagnosed Diabetes Mellitus Detected after First Acute Myocardial Infarction: from KAMIR-NIH Registry

  2018cites this paper
• Microfluidic auto-alignment of protein patterns for dissecting multi-receptor crosstalk in platelets.

  2018cites this paper
• Assessing the efficacy of aspirin and clopidogrel in patients with acute coronary syndromes

  2018cites this paper
• Thromboinflammatory Functions of Platelets in Ischemia–Reperfusion Injury and Its Dysregulation in Diabetes

  2018cites this paper
• Compression force sensing regulates integrin αIIbβ3 adhesive function on diabetic platelets

  2018cites this paper
• A Correlation between Diabetic Ischaemic Maculopathy and Platelet Indices

  2016cites this paper
• Analysis of platelet deposition and binding of anti-fibrinogen antibody to the artificial surfaces preadsorbed with sera or plasmas from patients with normal and elevated CRP

  2016cites this paper
• Recurrent vascular events in lacunar stroke patients with metabolic syndrome and/or diabetes

  2015influential citation
• Neonatal Platelet Function.

  2015cites this paper
• Гормональные, электролитные нарушения и особенности гемостаза у доношенных новорожденных детей от матерей с гестационным сахарным диабетом

  2015cites this paper
• SUBCUTANEOUS GLUCOSE BIOSENSOR FAILURE – A FUZZY FAULT TREE ANALYSIS APPROACH

  2014cites this paper
• Characteristics and Treatment Pattern of Diabetic Patients with ACS: A Saudi Perspective from the MIDAS Registry

  2013cites this paper
• Comparison of Platelet CD Markers between Normal Individuals and Untreated Patients with Type 2 Diabetes Mellitus

  2013cites this paper
• Assessment of Platelet Inhibition by Point-of-Care Testing in Neuroendovascular Procedures

  2013cites this paper
• Hyperglycemia and Stroke

  2013cites this paper
• Platelet Cd Markers By Flow Cytometry In Normal Individuals And In Patients With Untreated Type 2 Diabetes Mellitus

  2013cites this paper
• Diabetes , Platelet Dysfunction and Cardiovascular Events

  2012cites this paper
• Determination of normal range of bleeding time in rural and urban residents of Borujerd, Iran: A pilot study

  2012cites this paper
• The effect of the flavonols quercetin and 3', 4' dihydroxyflavonol on platelet function in vitro and in vivo

  2012cites this paper
• PLATELETS STRUCTURAL, FUNCTIONAL AND METABOLIC ALTERATIONS IN DIABETES MELLITUS

  2012cites this paper
• Endoplasmic-reticulum calcium depletion and disease.

  2011cites this paper
• Risk Stratification in Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction

  2011cites this paper
• Wound healing in diabetes: hemorheological and microcirculatory aspects.

  2011cites this paper
• Platelets : with special reference to platelet density subpopulations, stable coronary heart disease and atrial fibrillation

  2010cites this paper
• The role of calpain in diabetes-associated platelet hyperactivation.

  2010cites this paper
• Acute coronary syndromes in high risk groups: patients with diabetes, the elderly, and women

  2010cites this paper
• Barriers to Implementing an Insulin Order Form In a Non-ICU Medical Unit.

  2010cites this paper
• Platelet aggregation responses in type 2 diabetic patients

  2010cites this paper
• Treatment of cardiovascular risk factors in type 2 diabetes : time trends and clinical practice

  2010cites this paper
• Impaired Platelet Function in Neonates Born to Mothers with Diabetes or Hypertension During Pregnancy

  2010cites this paper
• EFFECTS OF IMPAIRED GLUCOSE METABOLISM, AGING AND METEOROLOGICAL FACTORS ON HEMORHEOLOGICAL PARAMETERS AND PLATELET AGGREGATION

  2009cites this paper
• Clinical outcome of patients with diabetes presenting with ST-elevation myocardial infarction and treated with concomitant use of glycoprotein IIb/IIIa inhibitors.

  2009cites this paper
• Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases.

  2009cites this paper
• Tratamiento médico de los pacientes con diabetes mellitus durante el período perioperatorio

  2008cites this paper
• Diabetes management in the hospital.

  2008cites this paper
• CHAPTER 19 – MEDICAL MANAGEMENT OF PATIENTS WITH DIABETES MELLITUS DURING THE PERIOPERATIVE PERIOD

  2008cites this paper
• Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)]

  2008cites this paper
• Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus‐eluting stents

  2008cites this paper
• Tratamiento de la diabetes en el hospital

  2008cites this paper
• Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial?

  2007cites this paper
• Antidiabetic Treatment In Diabetic Patients With Coronary Artery Disease

  2007cites this paper
• Effects of garlic on platelet biochemistry and physiology.

  2007cites this paper
• Platelet Function Changes in Different Cardiac Surgery Subgroups as Evaluated with an Innovative Technology

  2007cites this paper
• Examination of platelet function in whole blood under dynamic flow conditions with the cone and plate(let) analyzer: effect of erythrocytosis and thrombocytosis.

  2007cites this paper
• CHAPTER 38 – Diabetes Mellitus

  2007cites this paper
• Thrombin generation in the evaluation of hypercoagulable state in type 1 diabetic patients with diabetic retinopathy and without this complication

  2006cites this paper
• Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes.

  2006cites this paper
• The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests.

  2006cites this paper
• Flow‐based assays for global assessment of hemostasis. Part 2: current methods and considerations for the future 1

  2006cites this paper
• Nonsurgical Management of Chronic Wounds in Patients with Diabetes

  2006cites this paper
• Maternal Selective Serotonin Reuptake Inhibitor Intake Does Not Seem to Affect Neonatal Platelet Function Tests

  2006cites this paper
• Using Cone and Plate(let) Analyzer to Predict Bleeding in Cardiac Surgery

  2006cites this paper
• Behandeling van patiënten met diabetes mellitus type 2 en tevens coronaire hartziekten

  2006cites this paper
• Platelet Function of Newborns as Tested by Cone and Plate(let) Analyzer Correlates with Gestational Age

  2006cites this paper
• Diabetic patients with acute coronary syndromes in the UK: high risk and under treated. Results from the prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK).

  2005cites this paper
• Hydrogen peroxide and peroxynitrite enhance Ca2+ mobilization and aggregation in platelets from type 2 diabetic patients.

  2005cites this paper
• Prognosis and management of diabetic patients with acute coronary syndrome.

  2005cites this paper
• Pathobiology and cell interactions of platelets in diabetes

  2005cites this paper
• Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus.

  2005cites this paper
• Antiplatelet Agents in Patients Undergoing Percutaneous Coronary Intervention

  2005cites this paper
• Prevalence of aspirin resistance in patients with type 2 diabetes

  2005cites this paper
• Store-operated Ca2+ entry and tyrosine kinase pp60src hyperactivity are modulated by hyperglycemia in platelets from patients with non insulin-dependent diabetes mellitus

  2004cites this paper
• Increased platelet activation in young Zucker rats with impaired glucose tolerance is improved by acarbose

  2004cites this paper
• Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel

  2004influential citation
• Reduced Vascular NO Bioavailability in Diabetes Increases Platelet Activation In Vivo

  2004cites this paper
• Management of diabetes and hyperglycemia in hospitals.

  2004cites this paper
• Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention: analysis of 4,284 cases.

  2004cites this paper
• Influence of glucose concentration on the effects of aspirin, ticlopidine and clopidogrel on platelet function and platelet-subendothelium interaction.

  2004cites this paper
• Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.

  2004cites this paper
• Management of the patient with diabetes mellitus and myocardial infarction: clinical trials update.

  2004cites this paper
• The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial.

  2004cites this paper
• [Identifying myocardial ischaemia in diabetics. SFC/ALFEDIAM joint recommendations].

  2004cites this paper
• Percutaneous Coronary Intervention in Diabetics

  2004cites this paper
• [Strategy of investigation of coronary artery disease in diabetes: from screening to suspicion of acute coronary syndromes].

  2004cites this paper
• Ischemic heart disease and congestive heart failure in diabetic patients.

  2004cites this paper
• Store-operated Ca(2+) entry and tyrosine kinase pp60(src) hyperactivity are modulated by hyperglycemia in platelets from patients with non insulin-dependent diabetes mellitus.

  2004cites this paper
• Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes.

  2004cites this paper
• Characteristics of Platelet Surface Expression of Glycoprotein VI in Type 2 Diabetes

  2004cites this paper
• Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations.

  2004cites this paper
• Vascular and Platelet Function in Insulin Resistance

  2004cites this paper
• Identification de l'ischémie myocardique chez le diabétique

  2004cites this paper
• Embolization As a Pathological Mechanism

  2004cites this paper
• Intravenous Platelet Glycoprotein IIb/IIIa Inhibitors for Acute Coronary Syndromes

  2004cites this paper
• The Role of Glycoprotein IIb/IIIa-Receptor Antagonists in Diabetics

  2003cites this paper
• Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus.

  2003cites this paper
• Sind GPIIb/IIIa-Rezeptor-Antagonisten bei Diabetikern sinnvoll?

  2003cites this paper
• Modification of postprandial lipid profiles in people with diabetes

  2003cites this paper
• Platelet Chemokines and Chemokine Receptors: Linking Hemostasis, Inflammation, and Host Defense

  2003cites this paper
• Risk factors in coronary atherosclerosis athero-inflammation: the meeting point

  2003cites this paper
• Platelet abnormalities in diabetes mellitus

  2003cites this paper
• Influence of diabetes mellitus on heart failure risk and outcome

  2003cites this paper
• Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects

  2003cites this paper
• Clinical studies on coronary revascularization in patients with type 2 diabetes.

  2003cites this paper
• [The value of platelet function tests].

  2003cites this paper